Shandong Weigao Group Medical Polymer Co. Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000171
HKD
5.11
-0.09 (-1.73%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 20.01%

  • Healthy long term growth as Net Sales has grown by an annual rate of 27.91%
  • Company has very low debt and has enough cash to service the debt requirements
2

Flat results in Dec 24

3

With ROE of 1.91%, it has a Very Expensive valuation with a 1.05 Price to Book Value

4

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

HKD 22,702 Million ()

stock-summary
P/E

55.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

4.57%

stock-summary
Debt Equity

-0.17

stock-summary
Return on Equity

1.83%

stock-summary
Price to Book

0.86

Revenue and Profits:
Net Sales:
1,544 Million
(Quarterly Results - Dec 2013)
Net Profit:
-502 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.09%
0%
-7.09%
6 Months
-28.03%
0%
-28.03%
1 Year
3.02%
0%
3.02%
2 Years
6.9%
0%
6.9%
3 Years
-61.64%
0%
-61.64%
4 Years
-49.8%
0%
-49.8%
5 Years
-66.6%
0%
-66.6%

Shandong Weigao Group Medical Polymer Co. Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
27.91%
EBIT Growth (5y)
23.38%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.16
Sales to Capital Employed (avg)
0.20
Tax Ratio
33.01%
Dividend Payout Ratio
47.66%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
15.45%
ROE (avg)
20.01%

Valuation key factors

Factor
Value
P/E Ratio
55
Industry P/E
Price to Book Value
1.05
EV to EBIT
17.14
EV to EBITDA
14.53
EV to Capital Employed
1.06
EV to Sales
3.87
PEG Ratio
NA
Dividend Yield
3.68%
ROCE (Latest)
6.18%
ROE (Latest)
1.91%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'13 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2013 is 50.02% vs -1.52% in Dec 2012",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2013 is -275.70% vs -91.66% in Dec 2012",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'13",
        "Dec'12",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,544.20",
          "val2": "1,029.30",
          "chgp": "50.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "370.70",
          "val2": "251.20",
          "chgp": "47.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.20",
          "val2": "4.10",
          "chgp": "-46.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-501.80",
          "val2": "285.60",
          "chgp": "-275.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "195.30%",
          "val2": "203.10%",
          "chgp": "-0.78%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -2.94% vs -8.56% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 2.93% vs -33.60% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14,189.30",
          "val2": "14,618.50",
          "chgp": "-2.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,593.50",
          "val2": "3,497.80",
          "chgp": "2.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "270.60",
          "val2": "301.60",
          "chgp": "-10.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "29.20",
          "val2": "-10.20",
          "chgp": "386.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,344.90",
          "val2": "2,278.10",
          "chgp": "2.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "179.40%",
          "val2": "170.80%",
          "chgp": "0.86%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'13 - YoYstock-summary

Dec'13
Dec'12
Change(%)
Net Sales
1,544.20
1,029.30
50.02%
Operating Profit (PBDIT) excl Other Income
370.70
251.20
47.57%
Interest
2.20
4.10
-46.34%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-501.80
285.60
-275.70%
Operating Profit Margin (Excl OI)
195.30%
203.10%
-0.78%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2013 is 50.02% vs -1.52% in Dec 2012

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2013 is -275.70% vs -91.66% in Dec 2012

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
14,189.30
14,618.50
-2.94%
Operating Profit (PBDIT) excl Other Income
3,593.50
3,497.80
2.74%
Interest
270.60
301.60
-10.28%
Exceptional Items
29.20
-10.20
386.27%
Consolidate Net Profit
2,344.90
2,278.10
2.93%
Operating Profit Margin (Excl OI)
179.40%
170.80%
0.86%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -2.94% vs -8.56% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 2.93% vs -33.60% in Dec 2023

stock-summaryCompany CV
About Shandong Weigao Group Medical Polymer Co. Ltd. stock-summary
stock-summary
Shandong Weigao Group Medical Polymer Co. Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available